• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Medical devices; labeling for menstrual tampons; ranges of absorbency, change from "junior" to "light." Final rule.

出版信息

Fed Regist. 2004 Aug 25;69(164):52170-1.

PMID:15329983
Abstract

The Food and Drug Administration (FDA) is issuing a final rule that amends its menstrual tampon labeling regulation to change the current term for tampons that absorb 6 grams (g) and under of fluid. A tampon with absorbency of 6 g or less is currently required to be labeled as "junior". FDA is changing the term "junior" to "light". The term "junior" implies that the tampon is only for younger or teenage women when, in fact, it may be appropriate for women of any age with light menstrual flow. FDA encourages women to use the lowest absorbency tampon appropriate for their flow to help minimize the risk of Toxic Shock Syndrome (TSS). At present, FDA requires standardized terms to be used for the labeling of a menstrual tampon to indicate its particular absorbency. This rule enables women to compare the absorbency of one brand and style of tampons with the absorbency of other brands and styles. FDA is issuing this final rule under the Federal Food, Drug, and Cosmetic Act (the act) to ensure that labeling of menstrual tampons is not misleading.

摘要

相似文献

1
Medical devices; labeling for menstrual tampons; ranges of absorbency, change from "junior" to "light." Final rule.
Fed Regist. 2004 Aug 25;69(164):52170-1.
2
Medical devices; labeling for menstrual tampon for the "ultra" absorbency. Food and Drug Administration, HHS. Final rule.医疗器械;“超”吸收性月经棉条的标签。美国卫生与公众服务部食品药品监督管理局。最终规则。
Fed Regist. 2000 Oct 18;65(202):62282-5.
3
Clinical safety assessment of an ultra absorbency menstrual tampon.一种超吸收能力的月经棉条的临床安全评估。
J Womens Health (Larchmt). 2010 Feb;19(2):273-8. doi: 10.1089/jwh.2009.1423.
4
Amended economic impact analysis of final rule requiring use of labeling on natural rubber containing devices--FDA. Final rule; amended economic analysis statement.要求在含天然橡胶的器械上使用标签的最终规则的修订经济影响分析——美国食品药品监督管理局。最终规则;修订后的经济分析声明。
Fed Regist. 1998 Jun 1;63(104):29552-90.
5
Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases.经期女性中毒性休克综合征:与使用卫生棉条及金黄色葡萄球菌的关联及52例临床特征
N Engl J Med. 1980 Dec 18;303(25):1436-42. doi: 10.1056/NEJM198012183032502.
6
Toxic shock syndrome in Canada.加拿大的中毒性休克综合征。
Can Med Assoc J. 1982 Apr 1;126(7):776-9.
7
Amended economic impact analysis of final rule requiring use of labeling on natural rubber containing devices--FDA. Final rule; amended economic analysis statement.要求含天然橡胶器械使用标签的最终规则的修订经济影响分析——美国食品药品监督管理局。最终规则;修订后的经济分析声明。
Fed Regist. 1998 Aug 31;63(168):46171-4.
8
The relationship of tampon characteristics to menstrual toxic shock syndrome.卫生棉条特征与月经性中毒性休克综合征的关系。
JAMA. 1987 Aug 21;258(7):917-20.
9
Natural rubber-containing medical devices; user labelling--FDA. Final rule; interpretation.
Fed Regist. 1998 May 6;63(87):24934-5.
10
Natural rubber-containing medical devices; user labeling; cold seal adhesives partial stay--FDA. Final rule.
Fed Regist. 1998 Aug 31;63(168):46174-5.